FilingReader Intelligence
Jinyu Bio-Technology terminates share issuance plan
July 15, 2025 at 05:00 AM UTC•By FilingReader AI
Jinyu Bio-Technology terminated its 2023 A-share issuance to specific objects, citing changes in capital market conditions and strategic considerations.
The company forecast half-year net profit of RMB 57-70 million, down from the previous year due to increased R&D and depreciation costs.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
Primary Source Document
News Alerts
Get instant email alerts when Jinyu Bio-Technology publishes news
Free account required • Unsubscribe anytime